The field of cancer immunotherapy has achieved remarkable progress, introducing strategies such as immune checkpoint inhibitors and adoptive cell therapies ...

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at ...

Faculty from dental medicine, medicine and philosophy are working on the project that aims to better understand ...

How AI, robotics, and modular design are transforming single-cell and spatial biology into scalable, precision-driven engines of discovery.

Measuring membrane thickness was previously only possible in artificial membranes—now scientists can do it inside intact ...

Objective: To understand patient portal engagement stratified by patient characteristics among adults 50 years and older with at least 1 common chronic medical condition using electronic health ...

(NYSE: RVTY), today announced that it will release its fourth quarter and full year 2025 financial results prior to market open on Monday, February 2, 2026. The Company will host a conference call the ...

Our deep pipeline and cash runway into 2030 enable IDEAYA to advance key combinations and to address multiple indications ...

https://www.helmholtz-hzi.de/en/media-center/newsroom/news-detail/hips-and-beier... HZI Press release ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

Both the new weight loss drugs and bariatric (weight loss) surgery improve body composition in patients with obesity by ...

Tumor immunotherapy has rapidly emerged as a cornerstone in oncology, revolutionizing the treatment landscape for patients with advanced malignancies.